Substantial tumor growth inhibition, and complete remission without severe toxicity (6 of 18 mice), was observed in HT-1080 xenograft mice after [<sup>177</sup>Lu]Lu-EphA2 mAb (3 and 10 MBq) administration. Here, EPHA2 is linked to neoplasm.